Page 57 - Read Online

Pang et al. Mini-invasive Surg 2024;8:27 https://dx.doi.org/10.20517/2574-1225.2023.124 Page 11 of 11

carcinoma. Head Neck 2013;35:1726-31. DOI PubMed
45. Ding X, Lin QG, Zou X, et al. Transoral robotic retropharyngeal lymph node dissection in nasopharyngeal carcinoma with
retropharyngeal lymph node recurrence. Laryngoscope 2021;131:E1895-902. DOI PubMed
46. Ozer E, Waltonen J. Transoral robotic nasopharyngectomy: a novel approach for nasopharyngeal lesions. Laryngoscope
2008;118:1613-6. DOI PubMed
47. Tsang RK, Mohr C. Lateral palatal flap approach to the nasopharynx and parapharyngeal space for transoral robotic surgery: a
cadaveric study. J Robot Surg 2013;7:119-23. DOI PubMed PMC
48. Dallan I, Castelnuovo P, Montevecchi F, et al. Combined transoral transnasal robotic-assisted nasopharyngectomy: a cadaveric
feasibility study. Eur Arch Otorhinolaryngol 2012;269:235-9. DOI PubMed
49. Gorphe P, Stein H, Moya-Plana A. Cervical-transoral robotic nasopharyngectomy: a preclinical study. Head Neck 2020;42:394-400.
DOI PubMed
50. Tsang RK, Chan WCP, Holsinger FC, et al. Long-term results of robotic-assisted nasopharyngectomy for recurrent nasopharyngeal
carcinoma. Head Neck 2022;44:1940-7. DOI PubMed
51. Tsang RK, To VS, Ho AC, Ho WK, Chan JY, Wei WI. Early results of robotic assisted nasopharyngectomy for recurrent
nasopharyngeal carcinoma. Head Neck 2015;37:788-93. DOI PubMed
52. Mai HQ, Mo HY, Deng JF, et al. Endoscopic microwave coagulation therapy for early recurrent T1 nasopharyngeal carcinoma. Eur J
Cancer 2009;45:1107-10. DOI PubMed
53. Liu TR, Chen FJ, Qian CN, et al. Primary salivary gland type carcinoma of the nasopharynx: therapeutic outcomes and prognostic
factors. Head Neck 2010;32:435-44. DOI PubMed
54. Liu TR, Yang AK, Guo X, et al. Adenoid cystic carcinoma of the nasopharynx: 27-year experience. Laryngoscope 2008;118:1981-8.
DOI PubMed
55. You R, Zou X, Hua YJ, et al. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local
recurrence of selected T1-T3 nasopharyngeal carcinoma - a case-matched comparison. Radiother Oncol 2015;115:399-406. DOI
PubMed
56. Thamboo A, Patel VS, Hwang PH. 5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal
carcinoma. J Otolaryngol Head Neck Surg 2021;50:12. DOI PubMed PMC
57. Wei WI. Salvage surgery for recurrent primary nasopharyngeal carcinoma. Crit Rev Oncol Hematol 2000;33:91-8. DOI PubMed
58. Chan JY, Wei WI. Impact of resection margin status on outcome after salvage nasopharyngectomy for recurrent nasopharyngeal
carcinoma. Head Neck 2016;38 Suppl 1:E594-9. DOI PubMed
59. Chan JY, To VS, Chow VL, Wong ST, Wei WI. Multivariate analysis of prognostic factors for salvage nasopharyngectomy via the
maxillary swing approach. Head Neck 2014;36:1013-7. DOI PubMed
60. Lee AWM, Ng WT, Chan YH, Sze H, Chan C, Lam TH. The battle against nasopharyngeal cancer. Radiother Oncol 2012;104:272-8.
DOI PubMed
61. Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated
radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol
2012;104:286-93. DOI PubMed
62. Sun Y, Li WF, Chen NY, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy
alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol
2016;17:1509-20. DOI PubMed
63. Ma BBY, Lim WT, Goh BC, et al. Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an
international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742). J Clin Oncol 2018;36:1412-8. DOI PubMed
PMC
64. Huang H, Yao Y, Deng X, et al. Immunotherapy for nasopharyngeal carcinoma: current status and prospects (Review). Int J Oncol
2023;63:97. DOI PubMed PMC
65. Bossi P, Gurizzan C, Chan A. Immunotherapy for nasopharyngeal carcinoma: the earlier the better. JAMA 2023;330:1954-5. DOI
PubMed